Clinical trial
CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell…
NCT00333190 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00333190 |
|---|---|
| Title | CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation |
| Official title | CD8+ T Cell Depletion as Graft Versus Host Disease Prophylaxis After HLA-Matched Unrelated Donor Non-myeloablative Peripheral Blood Stem Cell Transplantation |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hematologic Malignancy, AML, ALL, CML, Multiple Myeloma, NHL, Hodgkin's Lymphoma |
| Intervention type | Device |
| Interventions | CD+8 T cell depletion |
| Enrollment | 30 |
| Start date | Sep 1, 2005 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2009 |
| First posted | Jun 2, 2006 |
| Last update posted | Mar 16, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: